Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
116.25
+0.06 (0.05%)
Nov 26, 2025, 4:00 PM EST - Market closed
Encompass Health Market Cap
Encompass Health has a market cap or net worth of $11.7 billion as of November 26, 2025. Its market cap has increased by 12.50% in one year.
Market Cap
11.70B
Enterprise Value
14.31B
1-Year Change
12.50%
Ranking
Category
Stock Price
$116.25
Market Cap Chart
Since December 1, 1998, Encompass Health's market cap has increased from $5.90B to $11.70B, an increase of 98.33%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 11.69B | 25.65% |
| Dec 31, 2024 | 9.30B | 39.12% |
| Dec 29, 2023 | 6.69B | 12.06% |
| Dec 30, 2022 | 5.97B | -8.08% |
| Dec 31, 2021 | 6.49B | -21.03% |
| Dec 31, 2020 | 8.22B | 20.38% |
| Dec 31, 2019 | 6.83B | 11.90% |
| Dec 31, 2018 | 6.10B | 25.66% |
| Dec 29, 2017 | 4.86B | 31.17% |
| Dec 30, 2016 | 3.70B | 16.34% |
| Dec 31, 2015 | 3.18B | -5.69% |
| Dec 31, 2014 | 3.38B | 15.85% |
| Dec 31, 2013 | 2.91B | 44.26% |
| Dec 31, 2012 | 2.02B | 19.97% |
| Dec 30, 2011 | 1.68B | -13.03% |
| Dec 31, 2010 | 1.94B | 10.51% |
| Dec 31, 2009 | 1.75B | 81.54% |
| Dec 31, 2008 | 964.70M | -41.73% |
| Dec 31, 2007 | 1.66B | -7.95% |
| Dec 29, 2006 | 1.80B | -7.60% |
| Dec 30, 2005 | 1.95B | -21.82% |
| Dec 31, 2004 | 2.49B | 36.82% |
| Dec 31, 2003 | 1.82B | 9.29% |
| Dec 31, 2002 | 1.67B | -71.36% |
| Dec 31, 2001 | 5.81B | -7.73% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |